• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Poland·Financial Services·IPE.WA
Share

IPOPEMA Securities S.A. Stocks

PLN 8.36Last Updated 26.10.2026

Issuer Rating

4/7
Performance

Strong

Risk

High

Recommendation

Hold

Market Cap

PLN 64.14M

PLN 8.36
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 2005 in Warsaw, Poland, IPOPEMA Securities S.A. is a financial services firm delivering a comprehensive range of brokerage, equity research, and investment banking solutions. The company's operations are organized into distinct divisions. Its Investment Fund and Portfolio Management segment focuses on the creation and oversight of various investment funds, including both open-end and closed-end structures, alongside managing portfolios of financial instruments for clients. The Brokerage and Investment Banking division undertakes securities brokerage, the distribution of investment products, and provides investment advisory services to individual investors. This extensive segment also covers a full spectrum of investment banking activities, such as the preparation and execution of equity capital market transactions, public securities offerings, mergers and acquisitions (M&A), and management buy-outs. Additionally, it offers expert advice on corporate financial restructuring, assists in securing funding for infrastructure projects, and guides clients through private market financing. IPOPEMA Securities S.A. further supports companies listed on the Warsaw Stock Exchange with share repurchase initiatives, including tender offers and buyback programs. Through its Advisory Service segment, the company delivers specialized expertise in business and management consulting, complemented by IT-related services such as computer facilities management, general IT advisory, and various software solutions. Beyond these primary financial offerings, IPOPEMA Securities S.A. also provides intermediation services and engages in the wholesale distribution of computer hardware, peripherals, equipment, and software.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, underpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.10.2026 09:01

Insiders, a competitor, a philanthropist, and an activist: Who owns shares in Anthropic?

28.10.2026 08:30

Wall Street has identified Broadcom as a major beneficiary of Anthropic's IPO. Who else stands to gain?

28.10.2026 08:01

"Too Big a Chicken": McDonald's Partners Deem the New Menu a Failure

28.10.2026 07:01

Healthcare stocks have become a bet against AI. Should you buy them?

28.10.2026 03:18

"The conditions for a rebound are ripe": Stocks rise for a second day ahead of big tech earnings reports

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026